Direct Determination of ECD in ECD Kit: a Solid Sample Quantitation Method for Active Pharmaceutical Ingredient in Drug Product

Overview

Journal J Biomed Biotechnol

Specialty Biology

Date 2011 Jun 21

PMID 21687539

Authors

Ming-Yu Chao

Kung-Tien Liu

Yi-Chih Hsia

Mei-Hsiu Liao

Lie-Hang Shen

Affiliations

Soon will be listed here.

Abstract

Technetium-99m ethyl cysteinate dimer (Tc-99m-ECD) is an essential imaging agent used in evaluating the regional cerebral blood flow in patients with cerebrovascular diseases. Determination of active pharmaceutical ingredient, that is, L-Cysteine, N, N'-1,2-ethanediylbis-, diethyl ester, dihydrochloride (ECD) in ECD Kit is a relevant requirement for the pharmaceutical quality control in processes of mass fabrication. We here presented a direct solid sample determination method of ECD in ECD Kit without sample dissolution to avoid the rapid degradation of ECD. An elemental analyzer equipped with a nondispersive infrared detector and a calibration curve of coal standard was used for the quantitation of sulfur in ECD Kit. No significant matrix effect was found. The peak area of coal standard against the amount of sulfur was linear over the range of 0.03-0.10 mg, with a correlation coefficient (r) of 0.9993. Method validation parameters were achieved to demonstrate the potential of this method.

References

Sunada I, Ishida T, Sakamoto S, Tsuyuguchi N . A discrepancy between Tc-99m HMPAO SPECT and Tc-99m ECD SPECT in Creutzfeldt-Jacob disease. J Clin Neurosci. 2004; 11(6):648-50. DOI: 10.1016/j.jocn.2003.08.012. View

Gryglewicz G, Gryglewicz S . Determination of elemental sulfur in coal by gas chromatography-mass spectrometry. Fresenius J Anal Chem. 2001; 370(1):60-3. DOI: 10.1007/s002160100756. View

Caroli A, Geroldi C, Nobili F, Barnden L, Guerra U, Bonetti M . Functional compensation in incipient Alzheimer's disease. Neurobiol Aging. 2008; 31(3):387-97. DOI: 10.1016/j.neurobiolaging.2008.05.001. View

Hyun I, Lee J, Rha J, Lee I, Ha C, Lee D . Different uptake of (99m)Tc-ECD and (99m)Tc-HMPAO in the same brains: analysis by statistical parametric mapping. Eur J Nucl Med. 2014; 28(2):191-7. DOI: 10.1007/s002590000437. View

Bauer M, Silverman D, Schlagenhauf F, London E, Geist C, van Herle K . Brain glucose metabolism in hypothyroidism: a positron emission tomography study before and after thyroid hormone replacement therapy. J Clin Endocrinol Metab. 2009; 94(8):2922-9. DOI: 10.1210/jc.2008-2235. View

Vallabhajosula S, Zimmerman R, Picard M, Stritzke P, Mena I, Hellman R . Technetium-99m ECD: a new brain imaging agent: in vivo kinetics and biodistribution studies in normal human subjects. J Nucl Med. 1989; 30(5):599-604. View

Jacquier-Sarlin M, Polla B, Slosman D . Cellular basis of ECD brain retention. J Nucl Med. 1996; 37(10):1694-7. View

Schraml F, Beason-Held L, Fletcher D, Brown B . Cerebral accumulation of Tc-99m ethyl cysteinate dimer (ECD) in severe, transient hypothyroidism. J Cereb Blood Flow Metab. 2005; 26(3):321-9. DOI: 10.1038/sj.jcbfm.9600191. View

Wielepp J, Burgunder J, Pohle T, Ritter E, Kinser J, Krauss J . Deactivation of thalamocortical activity is responsible for suppression of parkinsonian tremor by thalamic stimulation: a 99mTc-ECD SPECT study. Clin Neurol Neurosurg. 2001; 103(4):228-31. DOI: 10.1016/s0303-8467(01)00165-2. View

10.

Ukisu R, Kushihashi T, Tanaka E, Baba M, Usui N, Fujisawa H . Diffusion-weighted MR imaging of early-stage Creutzfeldt-Jakob disease: typical and atypical manifestations. Radiographics. 2006; 26 Suppl 1:S191-204. DOI: 10.1148/rg.26si065503. View

11.

Vanbilloen H, Cleynhens B, Verbruggen A . Importance of the two ester functions for the brain retention of 99mTc-labelled ethylene dicysteine diethyl ester (99mTc-ECD). Nucl Med Biol. 1998; 25(6):569-75. DOI: 10.1016/s0969-8051(98)00016-x. View

12.

Verduyckt T, Kieffer D, Huyghe D, Cleynhens B, Verbeke K, Verbruggen A . Identity confirmation of 99mTc-MAG3, 99mTc-sestamibi and 99mTc-ECD using radio-LC-MS. J Pharm Biomed Anal. 2003; 32(4-5):669-78. DOI: 10.1016/s0731-7085(03)00174-2. View

13.

Dormehl I, Oliver D, Langen K, Hugo N, Croft S . Technetium-99m-HMPAO, technetium-99m-ECD and iodine-123-IMP cerebral blood flow measurements with pharmacological interventions in primates. J Nucl Med. 1998; 38(12):1897-901. View

14.

Sieper H, Kupka H, Williams T, Rossmann A, Rummel S, Tanz N . A measuring system for the fast simultaneous isotope ratio and elemental analysis of carbon, hydrogen, nitrogen and sulfur in food commodities and other biological material. Rapid Commun Mass Spectrom. 2006; 20(17):2521-7. DOI: 10.1002/rcm.2619. View

15.

Flores 2nd L, Jinnouchi S, Nagamachi S, Ohnishi T, Futami S, Nakahara H . Retention of Tc-99m ECD in delayed SPECT of the brain. Ann Nucl Med. 1999; 13(1):1-4. DOI: 10.1007/BF03165420. View

16.

Tsopelas C, Smyth D . Characterization and quality control analysis of 99mTc-bicisate. J Nucl Med Technol. 2005; 33(2):89-93. View

17.

Leveille J, Demonceau G, De Roo M, Rigo P, Taillefer R, Morgan R . Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 2: Biodistribution and brain imaging in humans. J Nucl Med. 1989; 30(11):1902-10. View

18.

Borroni B, Anchisi D, Paghera B, Vicini B, Kerrouche N, Garibotto V . Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD. Neurobiol Aging. 2005; 27(1):24-31. DOI: 10.1016/j.neurobiolaging.2004.12.010. View

19.

Diler R, Reyhanli M, Toros F, Kibar M, Avci A . Tc-99m-ECD SPECT brain imaging in children with Tourette's syndrome. Yonsei Med J. 2002; 43(4):403-10. DOI: 10.3349/ymj.2002.43.4.403. View

20.

Chang C, Shiau Y, Wang J, Ho S, Kao A . Abnormal regional cerebral blood flow on 99mTc ECD brain SPECT in patients with primary Sjögren's syndrome and normal findings on brain magnetic resonance imaging. Ann Rheum Dis. 2002; 61(9):774-8. PMC: 1754217. DOI: 10.1136/ard.61.9.774. View